4//SEC Filing
Theagene Jean-Manasse 4
Accession 0001127602-25-011809
CIK 0001878313other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 4:41 PM ET
Size
5.2 KB
Accession
0001127602-25-011809
Insider Transaction Report
Form 4
Theagene Jean-Manasse
Director
Transactions
- Award
Stock Options
2025-04-04+20,291→ 20,291 totalExercise: $1.50From: 2025-04-04Exp: 2035-04-04→ Common Stock (20,291 underlying)
Footnotes (1)
- [F1]The stock options, granted on April 4, 2025 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.
Documents
Issuer
MAIA Biotechnology, Inc.
CIK 0001878313
Entity typeother
Related Parties
1- filerCIK 0001969857
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 4:41 PM ET
- Size
- 5.2 KB